论文部分内容阅读
[目的]探讨胺碘酮在腹部手术患者围手术期中室性心律失常的疗效,为腹部手术患者围手术期中室性心律失常的治疗提供依据。[方法]选取2007年6月～2009年2月治疗的腹部手术围手术期室性心律失常的35例患者为研究对象,将其随机分为观察组18例和对照组17例,其中观察组采用胺碘酮进行控制治疗,而对照组则采用索他洛尔进行控制治疗,后对两组患者的控制治疗效果及副作用进行比较分析。[结果]通过比较研究,笔者发现在腹部手术患者围手术期中室性心律失常的治疗中,胺碘酮不论在控制治疗效果还是副作用发生率方面均优于索他洛尔,两组比较,P均﹤0.05,差异均无统计学意义。[结论]在腹部手术患者围手术期中室性心律失常的治疗中,胺碘酮的效果迅速,副作用发生率低,值得临床应用及进一步研究探讨。
[Objective] To explore the efficacy of amiodarone in perioperative ventricular arrhythmia in patients undergoing abdominal surgery, and to provide basis for the treatment of ventricular arrhythmia in patients undergoing abdominal surgery. [Methods] Thirty-five patients undergoing perioperative ventricular arrhythmia during abdominal surgery from June 2007 to February 2009 were selected as study subjects and randomly divided into observation group (18 cases) and control group (17 cases), and observation group Amiodarone was used to control the treatment, while the control group was treated with sotalol, followed by two groups of patients with controlled treatment and side effects were compared. [Results] Through comparative study, the author found that amiodarone was superior to sotalol both in the control of the treatment effect and the incidence of side effects in the perioperative period of abdominal surgery in patients with ventricular arrhythmia, the two groups, P All <0.05, the difference was not statistically significant. [Conclusion] Amiodarone has a rapid effect and low incidence of side effects during the perioperative period of abdominal surgery in patients undergoing abdominal surgery, which is worthy of clinical application and further study.